Edwards Lifesciences target price raised to $115 from $101 by Piper Sandler
EW•Piper Sandler raised its target price for Edwards Lifesciences to $115 from $101.
Related News
JonesTrading assumes coverage of Prime Medicine with buy rating; target price $6
PRME•
Chimera declares fourth-quarter 2026 preferred dividends of up to $0.6343 per share
CIM•
Azul raises loan limit from subsidiary to R$ 800 million
AZUL•
Editas Medicine gets buy rating as JonesTrading assumes coverage with $8 target price
EDIT•
Wayfair raises target price to $140 from $132
W•